在现实世界中,严重喘的生物管理和坚持不同于生物:CHRONICLE研究结果结果
Dennis K Ledford1, Weily Soong2, Warner Carr3
1Morsani College of Medicine, University of South Florida, Tampa, Florida.
概括
大多数患有严重喘 (SA) 的患者表现出对生物疗法的良好坚持. 然而,在家中给药和更短的剂量间隔可能会导致延迟,这表明保险索赔数据可能会高估.
科学领域:
- 肺部病理学 肺部病理学
- 现实世界的证据.
- 药物监督 药物监督 药物监督
背景情况:
- 患者遵守生物疗法对于管理严重喘 (SA) 非常重要.
- 之前在SA的遵守评估依赖于潜在的有限的医疗保险索赔数据.
- 专家报告的数据提供了更准确的生物管理和坚持的观点.
研究的目的:
- 为了评估现实世界的生物管理和美国成年人严重喘的坚持.
- 为了比较不同生物剂和管理设置之间的坚持率.
- 确定影响严重喘生物治疗的因素.
主要方法:
- 长期研究 (NCT03373045) 是一项非干预性,现实研究,对美国成年人进行SA.
- 专家们报告了所有生物药物 (本拉利祖马布,杜皮卢马布,梅波利祖马布,奥马利祖马布,雷斯利祖马布) 的使用情况和地点.
- 通过覆盖日数 (PDC) 和获得相当于52周剂量的时间的比例来衡量坚持.
主要成果:
- 在严重喘患者的生物疗法中,覆盖日数 (PDC) 的中位数为87%.
- 在接受相当于52周的剂量时,观察到平均58天的延迟.
- 杜皮卢马布显示较低的PDC和较长的延迟;商业保险患者表现出更好的坚持.
结论:
- 严重喘患者通常表现出对生物治疗的良好坚持.
- 家庭用药和更短的剂量间隔可能与增加的坚持挑战有关.
- 专家报告的数据为生物坚持提供了有价值的见解,有可能纠正保险索赔的过高估计.
更多相关视频
09:58A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
22.5K
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
40.8K
相关概念视频
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:23Inhaled Medications
313
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
313
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
308
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
308
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
300
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
300
01:30Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
01:26COPD: Management Using Bronchodilators and Corticosteroids
244
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
244